These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8810168)

  • 1. Secondary prevention of coronary artery disease.
    Dietz T; Talley JD
    J Ark Med Soc; 1996 Aug; 93(3):139-41. PubMed ID: 8810168
    [No Abstract]   [Full Text] [Related]  

  • 2. Secondary prevention of coronary artery disease in elderly persons: a treatise on a report by the American Heart Association.
    Keller KB; Lemberg L
    Am J Crit Care; 2006 Sep; 15(5):514-8. PubMed ID: 16926374
    [No Abstract]   [Full Text] [Related]  

  • 3. [Primary coronary heart disease prevention in general practice. How does one recognize and define a risk patient?].
    Schwandt P
    MMW Fortschr Med; 1999 Oct; 141(43):26-8. PubMed ID: 10912117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary heart disease in women: update 2008.
    Wenger NK; Shaw LJ; Vaccarino V
    Clin Pharmacol Ther; 2008 Jan; 83(1):37-51. PubMed ID: 18043680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention of ischaemic heart disease in the elderly. Reduction of coronary risk factors].
    Cybulska B; Kłosiewicz-Latoszek L; Walczak A
    Kardiol Pol; 2003 Apr; 58(4):302-7. PubMed ID: 14517565
    [No Abstract]   [Full Text] [Related]  

  • 6. [Risk factor grading for prevention of coronary artery disease].
    Erbel R; Siffert W; Möhlenkamp S; Schmermund A
    Dtsch Med Wochenschr; 2003 Feb; 128(7):330-6. PubMed ID: 12584660
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of lipid disorders for coronary heart disease prevention according to International Atherosclerosis Society recommendations].
    Idzior-Waluś B
    Przegl Lek; 1999; 56(5):372-6. PubMed ID: 10554575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Krakow Program for Secondary Prevention of Ischaemic Heart Disease. Part II. Secondary prevention of ischaemic heart disease during hospitalization].
    Kawecka-Jaszcz K; Jankowski P; Pajak A; Dubiel J; Maciejewicz J; Piotrowski W; Smielak-Korombel W; Tracz W
    Przegl Lek; 2001; 58(11):956-63. PubMed ID: 11987835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critique of universal diet recommendations for prevention of coronary heart disease.
    Reiser R
    ASDC J Dent Child; 1982; 49(1):60-2. PubMed ID: 6948841
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessing risk for coronary heart disease: beyond Framingham.
    Cobb FR; Kraus WE; Root M; Allen JD
    Am Heart J; 2003 Oct; 146(4):572-80. PubMed ID: 14564309
    [No Abstract]   [Full Text] [Related]  

  • 11. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary heart disease and associated risk factors in Qazvin: a population-based study.
    Fakhrzadeh H; Bandarian F; Adibi H; Samavat T; Malekafzali H; Hodjatzadeh E; Larijani B
    East Mediterr Health J; 2008; 14(1):33-41. PubMed ID: 18557450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the knowledge of risk factors and the principles of prevention of primary ischemic heart disease].
    Witczak W; Kot K
    Kardiol Pol; 1988; 31(8):510-4. PubMed ID: 3244228
    [No Abstract]   [Full Text] [Related]  

  • 14. Reduction of myocardial ischemia with simvastatin in addition to conventional treatment in patients with chronic coronary artery disease.
    Verri V; Cunha AB; Tessarolo LE; Carneiro RC; Romêo Filho LJ
    Rev Port Cardiol; 2004 Sep; 23(9):1089-105. PubMed ID: 15587571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the value of mass screening for coronary risks.
    Leaman DM; Crawshaw SL; Zelis RF
    Pa Med; 1981 Feb; 84(2):29-31. PubMed ID: 6785708
    [No Abstract]   [Full Text] [Related]  

  • 16. [Secondary prevention is of significance for prognosis in coronary disease].
    de Faire U
    Lakartidningen; 1998 Oct; 95(42):4588-90, 4593-4. PubMed ID: 9814011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).
    Reiner Z; Mihatov S; Milicić D; Bergovec M; Planinc D;
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cracovian Program for Secondary Prevention of Ischaemic Heart Disease. The quality of care in the field of secondary prevention of ischaemic heart disease depends on where patients are treated in the postdischarge period].
    Jankowski P; Kawecka-Jaszcz K; Pajak A
    Przegl Lek; 2001; 58 Suppl 6():21-5. PubMed ID: 11873737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lipid metabolism disorders and the risk and prevention of ischemic heart disease].
    Rywik S; Wagrowska H
    Przegl Lek; 1987; 44(6):479-83. PubMed ID: 3685431
    [No Abstract]   [Full Text] [Related]  

  • 20. [Major nutrition-related risk factors of ischemic heart disease: dyslipoproteinemia, obesity, hypertension, glucose intolerance].
    Pados G
    Orv Hetil; 1999 Jul; 140(28):1563-72. PubMed ID: 10443132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.